Detalhe da pesquisa
1.
Male breast cancer: a disease distinct from female breast cancer.
Breast Cancer Res Treat
; 173(1): 37-48, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30267249
2.
Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer.
Breast Cancer Res Treat
; 171(1): 111-120, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29744674
3.
Treatment patterns and characteristics of European patients with castration-resistant prostate cancer.
BMC Urol
; 13: 58, 2013 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-24206580
4.
Preliminary report of the Hepatic Encephalopathy Assessment Driving Simulator (HEADS) score.
Ethn Dis
; 18(3): 357-64, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18785452
5.
Phase I Study of Seviteronel, a Selective CYP17 Lyase and Androgen Receptor Inhibitor, in Men with Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 24(21): 5225-5232, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30012563
6.
Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer.
Horm Cancer
; 9(2): 82-94, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29340907
7.
A recipient risk score for deceased donor renal allocation.
Am J Kidney Dis
; 49(2): 284-93, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17261431
8.
Constitutive androstane receptor agonist, TCPOBOP, attenuates steatohepatitis in the methionine choline-deficient diet-fed mouse.
World J Gastroenterol
; 13(42): 5635-41, 2007 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-17948939
9.
Improving utilization of deceased donor kidneys by matching recipient and graft survival.
Transplantation
; 82(1): 10-4, 2006 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16861934
10.
Improving the prediction of donor kidney quality: deceased donor score and resistive indices.
Transplantation
; 80(7): 925-9, 2005 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16249740
12.
Treatment endpoints for advanced cholangiocarcinoma.
Nat Clin Pract Gastroenterol Hepatol
; 1(1): 4-5, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16265019
13.
Matching graft to recipient by predicted survival: can this be an acceptable strategy to improve utilization of deceased donor kidneys?
Transplant Rev (Orlando)
; 22(3): 167-70, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18631872
14.
Proteasome inhibition induces hepatic stellate cell apoptosis.
Hepatology
; 43(2): 335-44, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16440346
15.
Proteasome inhibition attenuates hepatic injury in the bile duct-ligated mouse.
Am J Physiol Gastrointest Liver Physiol
; 291(4): G709-16, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16798723
16.
Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival.
Liver Transpl
; 12(3): 448-56, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16498656
17.
Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins.
Hepatology
; 44(1): 252-62, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16799968
18.
United Network for Organ Sharing's expanded criteria donors: is stratification useful?
Clin Transplant
; 19(3): 406-12, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15877806
19.
Caspase-8, death-receptor signaling, and hepatocarcinogenesis: the Fas and the furious.
Gastroenterology
; 129(5): 1790-2, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16285976